Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris
- 1 September 2019
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (5) , 655-660
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 20 references indexed in Scilit:
- The association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: a preliminary studyPerfusion, 2012
- Identification of Accelerometer Nonwear Time and Sedentary BehaviorResearch Quarterly for Exercise and Sport, 2011
- The Anti-Ischemic Mechanism of Action of Ranolazine in Stable Ischemic Heart DiseaseJACC, 2010
- Maximal exercise oxygen pulse as a predictor of mortality among male veterans referred for exercise testingEuropean Journal of Preventive Cardiology, 2009
- Antianginal Efficacy of Ranolazine When Added to Treatment With AmlodipineJACC, 2006
- Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-BlockersCirculation, 2005
- Comparative efficacy of ranolazine versus atenolol for chronic angina pectorisThe American Journal of Cardiology, 2005
- Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratificationHeart, 2000
- Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery diseaseJACC, 1995
- The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.Circulation, 1978